Showing results (201-210 of 228) with videos related to

Sort By:
Pageof 23
The Lancet. HIV|April 30, 2016
Botswana's progress toward achieving the 2020 UNAIDS 90-90-90 antiretroviral therapy and virological suppression goals: a population-based surveyTendani Gaolathe, Kathleen E Wirth, Molly Pretorius Holme, et al.
The Journal of Antimicrobial Chemotherapy|January 7, 2025
High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, BotswanaOntlametse T Choga, Goitseone M Lemogang, Wonderful T Choga, et al.
The Journal of Clinical Investigation|February 16, 2026
Immune correlates of HIV-1 rebound during broadly neutralizing antibody treatment in young childrenAischa Niesar, Melanie Lancien, Seohyun Hong, et al.
The Journal of Infectious Diseases|August 3, 2013
Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052)Jessica M Fogel, Lei Wang, Teresa L Parsons, et al.
Virus Evolution|December 25, 2024
Emergence of Omicron FN.1 a descendent of BQ.1.1 in BotswanaWonderful T Choga, Emanuele Gustani-Buss, Houriiyah Tegally, et al.
Veterinary Medicine and Science|April 29, 2023
Near-complete genome of SARS-CoV-2 Delta variant of concern identified in a symptomatic dog (Canis lupus familiaris) in BotswanaWonderful T Choga, Samantha L Letsholo, Chandapiwa Marobela-Raborokgwe, et al.
The Journal of Infectious Diseases|December 28, 2018
Phylogenetic Methods Inconsistently Predict the Direction of HIV Transmission Among Heterosexual Pairs in the HPTN 052 CohortRebecca Rose, Matthew Hall, Andrew D Redd, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 12, 2023
Rapid dynamic changes of FL.2 variant: A case report of COVID-19 breakthrough infectionWonderful T Choga, Gobuiwang Khilly Kurusa Gasenna, James Emmanuel San, et al.
Journal of the International AIDS Society|June 4, 2025
Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical dataShelly Karuna, Fatima Laher, Sufia Dadabhai, et al.
The Journal of Infectious Diseases|October 13, 2011
Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trialSusan H Eshleman, Sarah E Hudelson, Andrew D Redd, et al.
Pageof 23